Employees Provident Fund Board’s Organon & Co OGN Stock Holding History

Employees Provident Fund Board’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-251,044	Closed	-$7.01M	–	98
2022 Q4	$7.01M	Hold	251,044	–	–	0.2%	55
2022 Q3	$5.87M	Hold	251,044	–	–	0.17%	54
2022 Q2	$8.47M	Hold	251,044	–	–	0.19%	63
2022 Q1	$8.77M	Hold	251,044	–	–	0.15%	69
2021 Q4	$7.64M	Hold	251,044	–	–	0.13%	56
2021 Q3	$8.23M	Hold	251,044	–	–	0.14%	61
2021 Q2	$7.6M	Buy	+251,044	New	+$8.26M	0.13%	56

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Employees Provident Fund Board's OGN Position: Q1 2023 in Review

Employees Provident Fund Board sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 251,044 shares — an estimated $7.01M sold.

Employees Provident Fund Board first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $8.77M in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

Employees Provident Fund Board reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
Employees Provident Fund Board sold 251,044 Organon & Co shares in Q1 2023, an estimated $7.01M.
Employees Provident Fund Board first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
Employees Provident Fund Board's Organon & Co position peaked at $8.77M in Q1 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Employees Provident Fund Board's 13F filing for Q1 2023, filed 18 Mar 2026.